Human smooth muscle cells of the aorta and vena cava: Different sensitivity to the inhibition of proliferation by heparin in vitro
- 1 August 1985
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 63 (15) , 702-705
- https://doi.org/10.1007/bf01733113
Abstract
In this comparative study of the antiproliferative effect of heparin (average mol. weight 16 kD) a different heparin sensitivity between cultivated smooth muscle cells derived from the media of the human aorta and the vena cava is observed. Heparin induces a partial proliferation inhibition of 54% in the aortic- and 17% in the vena cava-derived smooth muscle cells on day seven. The increase in cell volume suggests a selection of larger volume subpopulation of cells or an influence on the G2-phase of the cell cycle. Heparin and heparin-like compounds may develop into future therapeutic drugs for the prevention of increased smooth muscsle cell proliferation after vessel wall injury.This publication has 10 references indexed in Scilit:
- Endothelial Cells in CulturePublished by S. Karger AG ,2015
- Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cellsJournal of Cellular Physiology, 1984
- Inhibition of vascular smooth muscle cell migration by heparin‐like glycosaminoglycansJournal of Cellular Physiology, 1984
- Endothelium, heparin, and the regulation of vascular smooth muscle cell growthPublished by Springer Nature ,1984
- Role of Heparin-Like Molecules in AtherogenesisPublished by Walter de Gruyter GmbH ,1983
- What controls smooth muscle phenotype?Atherosclerosis, 1981
- Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin.Proceedings of the National Academy of Sciences, 1981
- Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies.Circulation Research, 1980
- Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin.Circulation Research, 1980
- Suppression by heparin of smooth muscle cell proliferation in injured arteriesNature, 1977